Poland· PL-100210680
Revival Plus
A olmesartan medoxomil und diuretika product containing olmesartanum medoxomilum + hydrochlorothiazidum, registered in Poland by Menarini International Operations Luxembourg S.A.. The same ATC class is registered in 12 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Olmesartan medoxomil und diuretika is registered in 12 of 19 countries.
Countries holding a registration under ATC C09DA08 (olmesartan medoxomil und diuretika), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Olmesartan medoxomil und diuretika · ATC C09DA08
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Olmesartanum medoxomilum + Hydrochlorothiazidum
- Manufacturer
- Menarini International Operations Luxembourg S.A.
- Country
- Poland (PL)
- ATC code
- C09DA08
- ATC class
- Olmesartan medoxomil und Diuretika
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 7
- gtin05909990706983
- gtin05909990706990
- gtin05909990707003
- gtin05909990707058
- gtin05909990707065
- gtin05909990707072
- gtin05909990707089
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
80 interactions on record for olmesartan medoxomil und diuretika.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Olmesartan medoxomil und diuretika · interactions on record
80 records
80 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Olmesartan medoxomil und diuretika in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/fde704f4-9ab5-4b15-a022-02cf39920e11 GET /v1/drugs/fde704f4-9ab5-4b15-a022-02cf39920e11?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "20 mg + 25 mg",
"packaging": "05909990706983 ¦ Rp ¦ 51010\n10 tabl.\n05909990706990 ¦ Rp ¦ 51011\n14 tabl.\n05909990707003 ¦ Rp ¦ 51012\n28 tabl.\n05909990707058 ¦ Rp ¦ 51013\n50 tabl.\n05909990707065 ¦ Rp ¦ 51014\n56 tabl.\n05909990707072 ¦ Rp ¦ 51015\n98 tabl.\n05909990707089 ¦ Rp ¦ 51016\n500 tabl.",
"substance": "Olmesartanum medoxomilum 20 mg + Hydrochlorothiazidum 25 mg",
"common_name": "Olmesartanum medoxomilum + Hydrochlorothiazidum",
"pl_product_id": "100210680",
"pozwolenie_nr": "15495",
"auth_procedure": "MRP",
"authorisation_validity": "Bezterminowe"
}See everything about olmesartan medoxomil und diuretika.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.